日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Natural language processing to identify documented pain preceding radiation therapy for bone metastases

利用自然语言处理技术识别骨转移放射治疗前记录的疼痛

Chen, Jie Jane; Feng, Jean; Friesner, Isabel D; Chang, Chichi; Kenny, Clodagh; Elia, Marianna V; Ni, Lisa; Feng, Felix Y; Rabow, Michael W; Braunstein, Steve E; Boreta, Lauren C; Hong, Julian C

Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005

评估NRG-GU005研究中前列腺MRI的质量和PI-RADSv2.1最低技术标准的遵守情况

Alley, Stephanie; Tonneau, Marion; Olivié, Damien; Tempany-Afdhal, Clare M; Choyke, Peter L; Turkbey, I Baris; van der Heide, Uulke A; Ellis, Rodney J; Kadoury, Samuel; Boike, Thomas P; Pennington, J Daniel; Frazier, Arthur; Lawton, Colleen A F; Leong, Nelson; Mihai, Alina M; Morgan, Scott C; Solanki, Abhishek A; Michalski, Jeff M; Feng, Felix Y; Sandler, Howard M; Menard, Cynthia

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials

开发和验证一种人工智能数字病理生物标志物,用于预测高危前列腺癌男性患者在多项 III 期试验中从长期激素治疗和放射治疗中获益的情况

Armstrong, Andrew J; Liu, Vinnie Y T; Selvaraju, Ramprasaath R; Chen, Emmalyn; Simko, Jeffry P; DeVries, Sandy; Sartor, Oliver; Sandler, Howard M; Mohamad, Osama; Huang, Huei-Chung; Griffin, Jacqueline; Yamashita, Rikiya; Esteva, Andre; Tran, Phuoc T; Spratt, Daniel E; Carson, John Hi; Peters, Christopher; Gore, Elizabeth; Lee, Steve P; Monson, Jedidiah M; Augspurger, Mark E; El-Gayed, Ali; Rodgers, Joseph P; McKay, Rana; Morgan, Todd; Feng, Felix Y; Nguyen, Paul L

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

cfDNA片段组学指标和商业靶向测序panel的分析

Helzer, Kyle T; Sharifi, Marina N; Sperger, Jamie M; Chrostek, Matthew R; Bootsma, Matthew L; Reese, Shannon R; Taylor, Amy; Kaufmann, Katie R; Krause, Hannah; Schehr, Jennifer; Sethakorn, Nan; Kosoff, David; Kyriakopoulos, Christos E; Bassetti, Michael; Blitzer, Grace; Floberg, John; Sjöström, Martin; Armstrong, Andrew J; Beltran, Himisha; McKay, Rana R; Feng, Felix Y; O'Regan, Ruth; Wisinski, Kari B; Emamekhoo, Hamid; Wyatt, Alex W; Lang, Joshua M; Zhao, Shuang G

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

调节 PPARγ 通路可上调 NECTIN4,并增强嵌合抗原受体 (CAR) T 细胞疗法在膀胱癌中的疗效

Chang Kevin, Delavan Henry M, Yip Elizabeth, Kasap Corynn, Zhu Jun, Lodha Roshan, Liao Sheng-You, Berman Sarah C, Carretero-Gonzalez Alberto, Basar Merve, Gokturk Ozcan Gamze, Teo Min Yuen, Solit David B, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Ding Cornelia C K, Chan Emily, Steri Veronica, Porten Sima P, Koshkin Vadim S, Friedlander Terence W, Feng Felix Y, Lee John K, Wiita Arun P, Chu Carissa E, Chou Jonathan

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

抗体和 CAR 介导的巨噬细胞毒性的可利用机制

Liu Tianyi, Zhang Meng, Farsh Tatyanah, Li Haolong, Kishishita Audrey, Barpanda Abhilash, Leung Stanley G, Zhu Jun, Jung Hyuncheol, Hua Junjie Tony, Zhu Xiaolin, Kim Alexander B, Goo Young Ah, Son Minsoo, Kim Jaenyeon, Subramanian Aish, Sjöström Martin, Fuh Katherine C, Chapman Jocelyn S, Carnevale Julia, Gilbert Luke A, Lakkaraju Aparna, Bruno Peter M, Quigley David, Wiita Arun P, Feng Felix Y, DeSelm Carl J

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

NRG Oncology/RTOG 0521 3期试验表明,局部高危前列腺癌的转录组分析可改善预后,并揭示在根治性放疗联合雄激素抑制治疗中加入多西他赛的益处。

Phillips, Ryan M; Proudfoot, James A; Davicioni, Elai; Liu, Yang; Spratt, Daniel E; Simko, Jeff M; Den, Robert B; Pollack, Alan; Rosenthal, Seth A; Sartor, A Oliver; Sweeney, Christopher J; Attard, Gerhardt; Longoria, Leslie; Patel, Samir; Straza, Michael W; Efstathiou, Jason A; Shah, Amit B; Hoffman, Karen E; Rodgers, Joseph P; Sandler, Howard M; Feng, Felix Y; Tran, Phuoc T

Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer

基于数字病理学的人工智能生物标志物在转移性前列腺癌中的验证

Markowski, Mark C; Ren, Yi; Tierney, Meghan; Royce, Trevor J; Yamashita, Rikiya; Croucher, Danielle; Huang, Huei-Chung; Todorovic, Tamara; Chen, Emmalyn; Showalter, Timothy N; Carducci, Michael A; Chen, Yu-Hui; Liu, Glenn; Parker, Charles T A; Esteva, Andre; Feng, Felix Y; Attard, Gerhardt; Sweeney, Christopher J

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J